EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudie

Clinical outcome of ulcerative colitis with severe onset in children: a multicenter prospective cohort study

Ryusuke Nambu, Katsuhiro Arai, Takahiro Kudo, Takatsugu Murakoshi, Reiko Kunisaki, Tatsuki Mizuochi, Sawako Kato, Hideki Kumagai, Mikihiro Inoue, Takashi Ishige, Takeshi Saito, Atsuko Noguchi und 14 weitere

Journal of Gastroenterology · 2023

DOI: 10.1007/s00535-023-01972-1 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Gastroenterology, 2023. Verfasst von Ryusuke Nambu und 25 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Saitama Children's Medical Center, 1-2 Shintoshin, Chuo-Ku, Saitama, 3308777, Japan. nambee1231@gmail.co…. Hauptthemen laut MEDLINE: Colitis, Ulcerative. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Ministry of Health, Labour and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: As best practices for treating children with severe-onset ulcerative colitis remain controversial in the era of biologic agents, we prospectively investigated treatments and outcomes in a multicenter cohort. METHODS: Using a Web-based data registry maintained in Japan between October 2012 and March 2020, we compared management and treatment outcomes in an S1 group defined by a Pediatric Ulcerative Colitis Activity Index of 65 or more points at diagnosis with those in an S0 group defined by an index value below 65. RESULTS: Three hundred one children with ulcerative colitis treated at 21 institutions were included, with follow-up for 3.6 ± 1.9 years. Among them, 75 (25.0%) were in S1; their age at diagnosis was 12.3 ± 2.9 years, and 93% had pancolitis. Colectomy free rates in S1 were 89% after 1 year, 79% after 2, and 74% after 5, significantly lower than for S0 (P = 0.0003). Calcineurin inhibitors and biologic agents, respectively, were given to 53% and 56% of S1 patients, significantly more than for S0 patients (P < 0.0001). Among S1 patients treated with calcineurin inhibitors when steroids failed, 23% required neither biologic agents nor colectomy, similarly to the S0 group (P = 0.46). CONCLUSIONS: Children with severe ulcerative colitis are likely to require powerful agents such as calcineurin inhibitors and biologic agents; sometimes colectomy ultimately proves necessary. Need for biologic agents in steroid-resistant patients might be reduced to an extent by interposing a therapeutic trial of CI rather than turning to biologic agents or colectomy immediately.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeHumansChildCalcineurin InhibitorsProspective StudiesRetrospective StudiesTreatment OutcomeSteroidsBiological FactorsImmunosuppressive AgentsInfliximab

Stichwörter der Autor:innen

Calcineurin inhibitorsPediatricsSevere-onset ulcerative colitis

Substanzen

Calcineurin InhibitorsSteroidsBiological FactorsImmunosuppressive AgentsInfliximab

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Saitama Children's Medical Center, 1-2 Shintoshin, Chuo-Ku, Saitama, 3308777, Japan. nambee1231@gmail.com.
  • Center for Pediatric Inflammatory Bowel Disease, Division of Gastroenterology, National Center for Child Health and Development, Tokyo, Japan.
  • Department of Pediatrics, Faculty of Medicine, Juntendo University, Tokyo, Japan.
  • Department of Gastroenterology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
  • Inflammatory Bowel Disease Center, Yokohama City University Medical Center, Kanagawa, Japan.
  • Department of Pediatrics and Child Health, Kurume University School of Medicine, Fukuoka, Japan.

Förderung

  • Ministry of Health, Labour and Welfare

Zitieren

APA

Nambu, R., Arai, K., Kudo, T., Murakoshi, T., Kunisaki, R., Mizuochi, T., Kato, S., Kumagai, H., Inoue, M., Ishige, T., Saito, T., Noguchi, A., Yodoshi, T., Hagiwara, S. I., Iwata, N., Nishimata, S., Kakuta, F., Tajiri, H., Hiejima, E., …, & JPIBD-R (2023). Clinical outcome of ulcerative colitis with severe onset in children: a multicenter prospective cohort study. Journal of Gastroenterology. https://doi.org/10.1007/s00535-023-01972-1

Vancouver

Nambu R, Arai K, Kudo T, Murakoshi T, Kunisaki R, Mizuochi T, et al. Clinical outcome of ulcerative colitis with severe onset in children: a multicenter prospective cohort study. Journal of Gastroenterology. 2023. doi:10.1007/s00535-023-01972-1

BibTeX
@article{Nambu2023,
  author = {Nambu, Ryusuke and Arai, Katsuhiro and Kudo, Takahiro and Murakoshi, Takatsugu and Kunisaki, Reiko and Mizuochi, Tatsuki and Kato, Sawako and Kumagai, Hideki and Inoue, Mikihiro and Ishige, Takashi and Saito, Takeshi and Noguchi, Atsuko and Yodoshi, Toshifumi and Hagiwara, Shin-Ichiro and Iwata, Naomi and Nishimata, Shigeo and Kakuta, Fumihiko and Tajiri, Hitoshi and Hiejima, Eitaro and Toita, Nariaki and Mochizuki, Takahiro and Shimizu, Hirotaka and Iwama, Itaru and Hirano, Yuri and Shimizu, Toshiaki and JPIBD-R, JPIBD-R},
  title = {Clinical outcome of ulcerative colitis with severe onset in children: a multicenter prospective cohort study},
  journal = {Journal of Gastroenterology},
  year = {2023},
  doi = {10.1007/s00535-023-01972-1}
}
Kostenlos starten →